Category:
Published on: 12 Dec 2023
Partnership with Novartis Pharmaceuticals Canada Inc. has created a faster, easier way for patients to contribute to research
Patients can now digitally consent to be included in The Neuro’s Open Biobank (Clinical Biospecimen Imaging and Genetic Repository) and patient registry, providing a more efficient and easier way to help patients accelerate neurological disorder research and participate in clinical trials. The new platform is financially supported by Novartis Pharmaceuticals Canada Inc.
Category:
Published on: 16 Jun 2023
Goal is to accelerate research and let patients know how their data is helping find treatments
A $6M grant from Brain Canada will fund the creation of a new Open Science patient registry, to share data with researchers around the world and let patients see how their data is used to develop new treatments for neurological disorders.
Category:
Published on: 28 Apr 2023
The Neuro joins two other McGill-affiliated organizations in signing The Declaration on Research Assessment
The Neuro (Montreal Neurological Institute-Hospital) has joined the Douglas Research Centre (DRC) and the Canadian Open Neuroscience Platform (CONP) in signing the San Francisco Declaration on Research Assessment (DORA), an agreement that seeks to change how scholarly research contributions are valued in hiring, promotion, and funding decisions.
Category:
Published on: 10 Aug 2022
Five-point strategy will maximize the impact of research and maintain leadership in mental health research and care
Today the Douglas Research Centre (DRC) joins The Neuro’s Tanenbaum Open Science Institute (TOSI) as a partner in research data sharing and collaboration through the adoption of a set of institutional Open Science principles.
Category:
Published on: 29 Mar 2022
YCharOS is an independent quality assessment initiative to improve research results
An antibody characterization project with partners at The Neuro will be able to expand thanks to funding from Génome Québec.
Category:
Published on: 14 Mar 2022
Academia and industry collaborate to find new targets for neurological disease treatment
A new research collaboration between The Neuro (Montreal Neurological Institute-Hospital), Takeda Development Center Americas, Inc. and Roche will enable large-scale analysis of patient data to potentially find promising targets for drug development in neurological diseases.
Category:
Published on: 3 Feb 2022
To support 2021’s International Open Access Week, Pfizer commissioned Inspiring STEM Consulting to record a series of podcast interviews with experts working within clinical and medical disciplines. The objective was to share perspectives on the real-world impact and benefit of open science for patients and key stakeholders.
Category:
Published on: 25 Jan 2022
The Tanenbaum Open Science Institute (TOSI) at The Neuro welcomes the Hotchkiss Brain Institute as a new partner to transform brain research through Open Science
Category:
Published on: 28 Oct 2021
In 2019, an independent report commissioned by the City of Montreal demonstrated racial and social profiling by the Service de police de la Ville de Montréal (SPVM) targeting Black, Arab and Indigenous peoples, and young adults in particular. According to the data, Indigenous and Black people are four to five times more likely to be stopped by police than non-racialized people.
Category:
Published on: 14 Jul 2021
Leading antibody reagent and knockout cell line manufacturers team up to address life science reproducibility crisis
YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins, is pleased to announce the publication of its first characterization data and formation of its Industry Advisory Committee (IAC).
Category:
Published on: 22 Jun 2021
Large multi-site study accurately predicts damage to grey matter by disease
An international study has found a link between the brain’s network connections and grey matter atrophy caused by certain types of epilepsy, a major step forward in our understanding of the disease.
Category:
Published on: 2 Dec 2020
The Neuro proudly supports the Open COVID Pledge, which calls on academic institutions, industry, and other organizations to make their intellectual property available free of charge for use in ending the COVID-19 pandemic and minimizing its impact.
As the world’s first Open Science institution, The Neuro is committed to the open exchange of ideas, technologies and resources, in order to remove barriers to discovery.
Category:
Published on: 9 Apr 2020
The Neuro’s director has been a driving force in neurological disease research and Open Science leadership
Since 1957, The Gairdner Foundation has been recognizing the achievements of the world’s top researchers for their contributions to health science. This year, Dr. Guy Rouleau joins an elite group of scientists by receiving the Canada Gairdner Wightman Award.
Category:
Published on: 31 Mar 2020
Djavad Mowafaghian Foundation shares The Neuro’s open science vision to accelerate drug discovery and find new and effective treatments for autism spectrum disorders
Category:
Published on: 29 May 2018
Pages
